# Antimalarial Drugs Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
Overview of the Antimalarial Drugs Market
Roots Analysis has published a report on the global Antimalarial Drugs market, The global antimalarial drugs market size, valued at USD 1.13 billion in 2024, is projected to reach USD 1.19 billion in 2025 and USD 1.75 billion by 2035, representing a CAGR of 3.9% during the forecast period. This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.
Key Findings of the Study:
In terms of geographical regions, North America currently holds the highest atrial fibrillation treatment devices market share ( nearly 50%) .
Market Size in 2026: $9.6 Billion
Estimated Market Size in 2035: $29.0 Billion
CAGR (2026-2035): 13.1%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region
To know more about other segments within Antimalarial Drugs market, read here https://www.rootsanalysis.com/reports/antimalarial-drugs-market.html
Antimalarial Drugs Adoption in the Asia Pacific Region
Request for free sample, https://www.rootsanalysis.com/reports/antimalarial-drugs-market/request-sample.html
Competitive Landscape
The Antimalarial Drugs Market has multiple key players in the market, which are profiled in the report also-
Bayer(Germany)
Cipla (India)
GlaxoSmithKline (UK)
Lupin (India)
Mylan (US)
Merck (US)
Novartis (Switzerland)
Pfizer (US)
Roche(Switzerland)
Sanofi (France)
Sun Pharmaceuticals (India)
Teva Pharmaceuticals (Israel)
Zydus Healthcare (India)
There are more key players involved in Antimalarial Drugs market mentioned in the report
Key Market Segments
Antimalarial Drugs Market Segmentation Insights
The market report provides comprehensive information on antimalarial drugs developers who are currently active across various segments of the industry as mentioned in the table below.
Antimalarial Drugs Market : Market Segmentation
▪ Plasmodium Falciparum
▪ Plasmodium Vivax
▪ Plasmodium Malariae
▪ Plasmodium Ovale
▪ Antifolate Compounds
▪ Artemisinin Compounds
▪ Aryl Aminoalcohol Compounds
▪ Others
▪ Oral
▪ Injectables
▪ Treatment of Malaria
▪ Prevention of Malaria
▪ Hospital Pharmacy
▪ E-Commerce
▪ Retail Pharmacy
▪ Others
▪ North America
▪ Europe
▪ Asia-Pacific
▪ Middle East & Africa
▪ Latin America
▪ US
▪ Canada
▪ Mexico
▪ France
▪ Germany
▪ Italy
▪ Spain
▪ UK
▪ Rest of Europe
▪ China
▪ India
▪ Japan
▪ South Korea
▪ New Zealand
▪ Rest of the Asia-Pacific
▪ Egypt
▪ Iran
▪ Iraq
▪ Israel
▪ Saudi Arabia
▪ South Africa
▪ United Arab Emirates
▪ Argentina
▪ Brazil
Industry Experts on Antimalarial Drugs Market
The antimalarial drug industry is constantly witnessing an upward trajectory as players are focusing on the development of resistance-free antimalarial drugs to mitigate the concern of drug resistance. A recent success in antimalarial drugs has been shared by the Karine Le Roche, ( professor of molecular, cell and systems biology, University of California, Riverside ).
“We’ve now shown mechanistically how RAP proteins regulate translation in an organelle that’s completely foreign to the human body.” “This evolutionary expansion suggests that RAP proteins may perform parasite-specific functions, making them exciting drug targets to treat malaria in the future”.
Key Questions Answered in the Report-
Market Share by Type of Malaria: Why Plasmodium Falciparum Segment Holds the Highest Share?
Market Share by Type of Drug Class: How Antifolate Compounds are Holding Maximum Share of The Market?
Market Share by Route of Administration: Does Oral Segment Continue to Dominate the Market?
Market Share by Mechanism of Action: How Antimalarial Drugs are Effective in the Treatment of Malaria?
Market Share by Distribution Channel: Why Hospital Pharmacy is the Primary Distributor of Antimalarial Drugs?
Market Share by Geographical Regions: Why is North America Holding the Maximum Share of the Market?
Market Drivers: What are the Main Drivers Behind Increased Antimalarial Drug Demand?
Market Challenges: Are Drug-Resistant Malaria Strains Impacting Drug Development?
Market Trends : What Innovations or New Drug Classes are in The Pipeline for Malaria Treatment?
Antimalarial Drugs Market Size Analysis: Which Regions are Seeing the Highest Use of Antimalarial Drugs?
To read more about key questions answered and market insights, you can refer to the full report by Roots Analysis, https://www.rootsanalysis.com/reports/antimalarial-drugs-market.html
Biologics Safety Testing Market
Radiopharmaceuticals Market
Laboratory Information Management Systems Market
Cell and Gene Therapy Manufacturing Market
Flow Cytometry Market